A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer

BACKGROUND: Few studies have investigated the clinical efficacy of third- and later-line of chemotherapy after standard chemotherapy for previously treated advanced non-small cell lung cancer (NSCLC). We prospectively evaluated the efficacy and safety of nanoparticle albumin-bound paclitaxel (nab-pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Yasuhiro, Okuma, Yusuke, Watanabe, Kageaki, Yomota, Makiko, Kawai, Shoko, Hosomi, Yukio, Okamura, Tatsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647220/
https://www.ncbi.nlm.nih.gov/pubmed/30993397
http://dx.doi.org/10.1007/s00280-019-03843-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647220/
https://www.ncbi.nlm.nih.gov/pubmed/30993397
http://dx.doi.org/10.1007/s00280-019-03843-0

Ejemplares similares